查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1791410

全球危險藥物調配系統市場報告：趨勢、預測和競爭分析（～2031年）

Hazardous Drug Compounding System Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球危險藥物調配系統市場前景光明，醫院藥局、門診/社區藥局以及研發實驗室都蘊藏著巨大的機會。預計2025年至2031年期間，全球危險藥物調配系統市場規模的年複合成長率將達到20.2%。推動該市場發展的關鍵因素包括安全法規的加強、危險藥物使用量的增加以及對醫護人員安全的重視。

  • Lucintel 預測，由於對無污染診斷劑的需求不斷成長，以確保 PCR 測試的準確性和可靠性，無菌混合系統將在預測期內繼續成為一個重要的領域。
  • 根據應用，由於對穩定、即用型試劑的需求不斷成長，以減少醫院實驗室的設置時間，預計醫院藥房將繼續成為最大的細分市場。
  • 依地區分類，預計北美在預測期內將經歷最高的成長。

危險藥品調配系統市場的新趨勢

危險藥物調配系統市場透過與提高安全性、效率和法規遵循相關的幾個新興趨勢不斷發展。

  • 危險藥物調配自動化：危險藥物調配市場最突出的趨勢之一是自動化。諸如機器人配製系統和封閉式藥物轉移裝置等自動化系統因其能夠最大限度地減少人為錯誤和危險藥物暴露而日益普及。此類技術提高了配製過程的準確性、一致性和安全性，尤其是在腫瘤診所等高風險環境中，同時也減少了醫護人員接觸危險化學品的風險。
  • 封閉式藥物轉運裝置（CSTD）需求日益成長：CSTD 是防止藥物污染和暴露的固有工具，其需求日益成長。 CSTD 目的是防止危險藥物在運輸過程中釋放到環境中。隨著 FDA 和 OSHA 等監管機構對其使用的日益重視，CSTD 的使用預計將持續成長。 CSTD 特別目的是降低化療藥物和其他危險藥物的暴露風險，進而保障醫護人員和病患的安全。
  • 配藥技術的改進：配藥技術系統的進步使配藥系統在配藥方面更加精確高效，提高了危險藥物使用的準確性和安全性。技術創新包括透過改進密封系統來提高劑量準確性，這是防止交叉污染和準確給藥的關鍵。技術進步不斷促使醫療保健機構更新其配藥系統，採用更新的模型，以維持安全和法規的高標準。
  • 監管變化與合規性：世界各國政府和監管機構加強監管，並實施更嚴格的危險藥物調配標準。製藥公司和醫療機構投資符合這些新標準的設備。這一趨勢推動了市場對更安全、合規的配製系統的需求。對監管合規性的日益重視，使得危險藥物的處理更加安全，目的是保護醫護人員和患者免受危險物質的侵害。
  • 工人安全：工人安全仍然是危險藥物調配過程中最重要的部分。人們日益關注危險藥物對醫護人員和勞工的健康危害，促使人們更加重視開發保護工人接觸的系統。這些系統包括隔離器、密閉裝置和個人防護設備，以最大限度地減少與這些藥物的直接接觸。對工人安全的日益關注預計將成為先進配製系統需求的強勁驅動力。
  • 全球危險藥品配製系統市場趨勢：封閉式藥物轉運裝置、技術進步、法規合規性、工人安全和自動化等趨勢改變全球危險藥品配製系統市場。隨著這些趨勢的不斷發展，市場預計將隨著藥物調配過程中對安全性、效率和過程合規性日益成長的需求而不斷發展。

危險藥物調配系統市場的最新發展

影響危險藥物調配系統市場的關鍵發展包括安全性、技術和法規遵循的改善。

  • 自動配藥系統：自動配藥系統廣泛應用，以提高藥物製備的準確性和安全性。這些系統可以最大限度地減少人為錯誤，提高效率，並能夠安全地處理危險藥物。醫療保健領域對自動化的需求日益成長，這加速了這些系統的普及，尤其是在腫瘤治療中心等高風險環境中。這些系統不僅最佳化了流程，還幫助醫療機構遵守嚴格的安全標準。
  • 封閉式藥物轉運裝置：封閉式藥物轉運裝置目的是防止危險藥物在運輸過程中洩漏，避免污染和暴露風險，並確保更有效率的藥物調配作業。隨著全球監管機構不斷強調藥物調配安全性，醫療機構也要求為其服務購買封閉式系統。在這些機構中，處理危險藥物和化療治療服務區正逐漸成為常態。
  • 提升安全性的監管措施：各國政府和監管機構加強危險藥物調配的安全措施。 FDA 和 OSHA 指南的修訂版等新法規迫使醫療機構實施更安全的業務，並投資先進的配製系統。這些法規降低了醫護人員接觸危險藥物的風險，並確保藥物調配的準確性和安全性。
  • 改良的密閉和隔離技術：密閉和隔離技術的改進使危險藥物的配製更加安全。包括隔離器和生物安全櫃在內的新型密閉系統開發中，以防止接觸危險藥物。這些技術透過創造安全的藥物調配環境，提高了醫護人員的防護。隨著這些技術的進步，預計將被世界各地的醫院和藥房擴大採用。
  • 重視訓練和教育：隨著人們對危險藥物安全問題的擔憂日益加深，對配發這些藥物的醫護人員進行培訓和教育也已成為關鍵問題。相關培訓計畫已陸續推出，目的是確保這些醫護人員充分了解相關風險並了解如何處理危險藥物。此外，市場上也湧現一些關於危險藥物的教育舉措，目的是提升醫護人員的知識和技能。

自動配藥系統、CSTD、監管措施、密閉技術進步以及對培訓的日益重視等發展，都使危險藥品配藥系統市場變得更加安全、高效和合規。基礎設施的持續發展將顯著改善危險藥品的處理，並確保醫護人員的安全。

目錄

第1章 執行摘要

第2章 市場概述

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球危險藥物調配系統市場（依類型）

  • 概述
  • 依類型的吸引力分析
  • 無菌複合系統：趨勢與預測（2019-2031）
  • 非無菌複合系統：趨勢與預測（2019-2031）

第5章 全球危險藥物調配系統市場（依應用）

  • 概述
  • 依用途的吸引力分析
  • 醫院藥局：趨勢與預測（2019-2031）
  • 門診/社區藥局：趨勢與預測（2019-2031）
  • 研發實驗室：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 全球危險藥品分配系統市場（依地區）

第7章 北美危險藥物調配系統市場

  • 概述
  • 北美危險藥品分配系統市場（依類型）
  • 北美危險藥物複合系統市場（依應用）
  • 美國危險藥物調配系統市場
  • 墨西哥危險藥品分配系統市場
  • 加拿大危險藥物調配系統市場

第8章 歐洲危險藥物調配系統市場

  • 概述
  • 歐洲危險藥品分配系統市場（依類型）
  • 歐洲危險藥物調配系統市場（依應用）
  • 德國危險藥品分配系統市場
  • 法國危險藥品分配系統市場
  • 西班牙危險藥品分配系統市場
  • 義大利危險藥品分配系統市場
  • 英國危險藥物調配系統市場

第9章 亞太地區危險藥物調配系統市場

  • 概述
  • 亞太地區危險藥品分配系統市場（依類型）
  • 亞太地區危險藥品分配系統市場（依應用）
  • 日本危險藥品配製系統市場
  • 印度危險藥品分配系統市場
  • 中國危險藥品分配系統市場
  • 韓國危險藥品配製系統市場
  • 印尼危險藥品分配系統市場

第10章 世界其他地區危險藥物調配系統市場

  • 概述
  • 世界其他地區危險藥物調配系統市場（依類型）
  • 世界其他地區危險藥物調配系統市場（依應用）
  • 中東危險藥品分配系統市場
  • 南美洲危險藥品分配系統市場
  • 非洲危險藥物調配系統市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 全球危險藥物調配系統市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業概況

  • 競爭分析
  • BD Medical
  • Equashield
  • ICU Medical
  • Simplivia
  • B. Braun
  • Baxter
  • Comecer
  • Grifols
  • ARxiUM
  • Newlcon

第14章 附錄

  • 圖表一覽
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global hazardous drug compounding system market looks promising with opportunities in the hospital pharmacies, outpatient/community pharmacies, and research and development laboratories markets. The global hazardous drug compounding system market is expected to grow with a CAGR of 20.2% from 2025 to 2031. The major drivers for this market are the increasing safety regulations, the rising use of hazardous drugs, and the focus on improving healthcare worker safety.

  • Lucintel forecasts that, within the type category, sterile compounding systems will remain the larger segment over the forecast period due to rising demand for contamination-free diagnostic reagents to ensure accuracy and reliability in PCR testing.
  • Within the application category, hospital pharmacies will remain the largest segment due to increasing demand for stable, ready-to-use reagents that reduce preparation time in hospital laboratories.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Hazardous Drug Compounding System Market

The hazardous drug compounding system market is evolving through several emerging trends that are concerned with the betterment of safety, efficiency, and regulatory compliance.

  • Hazardous Drug Compounding Automation: One of the most prominent trends in the hazardous drug compounding market is automation. Automated systems, such as robotic compounding systems and closed-system drug transfer devices, are being adopted increasingly due to their potential to minimize human error and exposure to dangerous drugs. Such technologies improve the accuracy, consistency, and safety of the compounding process so that healthcare workers are not exposed to hazardous chemicals, especially in high-risk environments like oncology clinics.
  • Emerging Demand for Closed System Transfer Devices (CSTDs): There is a rising demand for CSTDs that act as an inherent tool in preventing the contamination and exposure of drugs. CSTDs are a system designed to prevent hazardous drugs from escaping into the environment while transferring, and their usage will continue to grow as regulatory agencies such as the FDA and OSHA place emphasis on using them. Particularly, CSTDs are aimed at reducing risk in exposure to chemotherapy agents and other hazardous drugs, hence safety for both the healthcare workers and the patients.
  • Improved Compounding Technology: Advances in technological systems in compounding are ensuring that more exact and efficient preparations of drugs by the compounding system enhance accuracy and safety in the use of hazardous drugs. Innovations in technology consist of better dosing accuracy with improved containment systems which are a gateway to the absence of cross-contamination and correct doses of drugs. Technological advances keep pushing healthcare institutions to update newer models of compounding systems for sustained high standards on safety and regulations.
  • Regulatory Changes and Standards Compliance: Governments and regulatory agencies around the world are tightening regulations and enforcing stricter standards for hazardous drug compounding. Pharmaceutical companies and healthcare facilities are investing in equipment that meets these new standards. This trend is driving the market for safer, more compliant compounding systems. The increased focus on regulatory compliance ensures that hazardous drugs are handled more safely, with the goal of protecting both healthcare workers and patients from exposure to dangerous substances.
  • Worker Safety: Worker safety continues to be the most essential aspect of hazardous drug compounding. Given increased concerns regarding the health hazards of hazardous drugs to healthcare personnel and workers, there is more effort put into developing systems that safeguard worker exposure. These systems are defined as isolators, containment devices, and personal protective equipment that minimize direct contact with these drugs. This growth in focus on worker safety will be a strong factor in the demand for advanced systems of compounding.
  • Global Hazardous Drug Compounding System Market Trends: Closed-system transfer devices, advancements in technology, regulatory compliance, worker safety, and automation trends are transforming the global hazardous drug compounding system market. As these trends continue evolving, the market is expected to advance as well as develop, based on an increase in demand for safety, efficiency, and compliance with processes in drug compounding.

Recent Developments in the Hazardous Drug Compounding System Market

Some of the key developments influencing the hazardous drug compounding system market are safety, technology, and regulatory compliance improvements.

  • Automated Compounding Systems: Automated compounding systems are being put in place to develop greater accuracy and safety for drug preparation. These systems minimize the human error aspects, efficiency, and safely working with hazardous drugs. The expanding demand for automation in healthcare is accelerating the uptake of these systems, especially in high-risk settings like oncology treatment centers. These systems are facilitating healthcare providers' observance of strict standards on safety while optimizing the process.
  • Closed-system Drug Transfer Devices: Closed-system drug transfer devices, designed to avoid releasing hazardous drugs while the transfer is undergoing, ensure drug compounding operations are more effective in avoiding the risk of contamination and exposure. Since all regulatory agencies all over the globe are insisting that safety in compounding is promoted, healthcare institutions are demanding the purchase of closed systems for their services. In these facilities, it's becoming a standard with hazardous drugs' handling and a chemotherapy treatment service area.
  • Regulatory Initiatives to Improve Safety Measures: Governments and regulatory agencies are tightening safety measures for hazardous drug compounding. New regulations, such as the revised guidelines of the FDA and OSHA, are compelling healthcare facilities to take safer practices and invest in advanced compounding systems. These regulations will reduce the risk of hazardous drug exposure for healthcare workers and ensure that drugs are compounded accurately and safely.
  • Improvements in Containment and Isolation Technology: Improved containment and isolation technology have enhanced the safety of hazardous drug compounding. New containment systems, including isolators and biological safety cabinets, are being developed to prevent exposure to hazardous drugs. These technologies provide improved protection for healthcare workers by creating secure environments for drug compounding. As these technologies advance, they are expected to increase their adoption in hospitals and pharmacies around the world.
  • Focus on Training and Education: The number of safety concerns about hazardous drugs is on the rise, and so is the training and education of healthcare workers in compounding these drugs. Training programs are being designed to ensure that these workers are well equipped with the dangers and handling of these hazardous drugs. Moreover, educational initiatives related to hazardous drugs have appeared on the market to enhance the knowledge and skills of healthcare professionals.

All these advancements about developing automated compounding systems, CSTDs, regulatory initiatives, advancement in containment technology, and high focus on training are making the hazardous drug compounding system market safer, more efficient, and compliant. As these development infrastructures continue to pop up, they would significantly improve the handling of hazardous drugs and safeguard the healthcare worker.

Strategic Growth Opportunities in the Hazardous Drug Compounding System Market

The global market for hazardous drug compounding systems comprises several growth prospects across key applications that include oncology drug compounding.

  • Oncology Drug Compounding: The greatest growth opportunity in hazardous drug compounding systems is represented by oncology drug compounding. This fact is supported by the increasing incidence of cancer, coupled with the growing demand for chemotherapy drugs and treatment. Automated systems and CSTDs are particularly advantageous in oncology environments to prevent both contamination and exposure of toxic chemotherapy agents.
  • Pharmacy Compounding Services: Pharmacy compounding services are the other area of growth, as healthcare providers seek customized medicines for patients. As regulations for compounding hazardous drugs are tightened, pharmacies opt for advanced systems that can meet the safety standards in preparation while assuring the exact drug preparation. The growth of personalized medicine and patient-specific formulations of drugs is going to keep up the demand for hazardous drug compounding systems in the pharmacies.
  • Hospital and Clinic Adoption: Hazardous drug compounding systems are very important to hospitals and clinics that offer chemotherapy treatment. There is a growing interest in worker safety and regulatory compliance, which will cause healthcare facilities to adopt more advanced compounding technologies. These systems ensure accurate and safe drug preparation and are, therefore, essential in settings where patient safety and staff protection are the most important concerns.
  • Veterinary Applications: Hazardous drug compounding systems have growing applications in veterinary medicine. As the use of hazardous drugs in veterinary oncology and other treatments increases, so does the need for systems that can compound and prepare them safely. Veterinary clinics and hospitals are incorporating automated compounding systems into their facilities to make the preparation of drugs safer and more efficient. Growth in this sector is becoming a result of adapting to such changes.
  • Environmental and Safety Monitoring: The hazardous drug compounding market is witnessing an emerging growth opportunity in the form of environmental and safety monitoring. Importantly, monitoring systems assure the safe handling of hazardous drugs and track the resultant exposure levels; these are impacting significantly. Since healthcare facilities must comply with regulatory standards and maintain a safe environment for workers, there is much demand for comprehensive safety and environmental monitoring solutions.

These growth opportunities are based on oncology drug compounding, pharmacy services, hospital and clinic adoption, veterinary applications, and environmental monitoring, and will shape the future of the hazardous drug compounding system market. Demand for safer, more efficient systems will continue to drive market expansion based on these applications.

Hazardous Drug Compounding System Market Driver and Challenges

There are several drivers and challenges that are influencing the hazardous drug compounding system market, which includes technological, regulatory, and economic factors.

The factors responsible for driving the hazardous drug compounding system market include:

1. Advancements in Compounding Technology: Technological advancement is one of the major factors propelling the hazardous drug compounding system market. New automated systems, improved drug transfer devices, and containment technologies enhance the safety and efficiency of the drug compounding process. The innovation makes it easy for healthcare facilities to comply with the regulatory requirements and ensure the safety of healthcare workers and patients.

2. Focus on Worker Safety: With increased awareness regarding the risks of harmful drugs, there is a great need for safer compounding systems. There is an increasing emphasis on healthcare worker safety, which drives the adoption of technologies designed to minimize harmful exposures to hazardous substances. It is these increases in worker safety that are moving the markets toward greater advances in more protective compounding solutions.

3. Toughest Regulatory Standards: Stricter regulations by the FDA and OSHA for hazardous drug compounding are stimulating the growth in the hazardous drug compounding system market. In this regard, stringent regulations demand healthcare facilities to adopt safer methods of drug compounding, resulting in the rising demand for sophisticated systems that will meet these standards.

Challenges in the hazardous drug compounding system market are:

1. High Costs of Advanced Systems: The cost of advanced hazardous drug compounding systems is a significant challenge, especially for smaller healthcare facilities. These systems often require significant investments in equipment and training. High costs may deter the widespread adoption of these systems, especially in developing regions.

2. Regulatory Compliance Issues: While regulatory guidelines are pushing innovation, navigating the complex regulatory landscape for hazardous drug compounding systems is challenging. Constant updates to equipment and processes are necessary to keep pace with evolving safety standards, which can be time-consuming and costly for healthcare facilities.

3. Low awareness in emerging markets: The lack of awareness of drug compounding safety in hazardous situations in emerging markets is a key challenge to this market's growth. Most developing regions' hospitals and healthcare settings do not possess the necessary materials and knowledge base to implement leading-edge compounding systems. An awareness campaign concerning the need to compound drugs is essential for business expansion in those regions.

The hazardous drug compounding system market is driven by technological advancements, a focus on worker safety, and regulatory guidelines. Challenges such as high costs, regulatory compliance, and limited awareness in emerging markets are expected to impact the sustainability of market growth.

List of Hazardous Drug Compounding System Companies

  • Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, hazardous drug compounding system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hazardous drug compounding system companies profiled in this report include:
  • BD Medical
  • Equashield
  • ICU Medical
  • Simplivia
  • B. Braun
  • Baxter
  • Comecer
  • Grifols
  • ARxiUM
  • Newlcon

Hazardous Drug Compounding System Market by Segment

The study includes a forecast for the global hazardous drug compounding system market by type, application, and region.

Hazardous Drug Compounding System Market by Type [Value from 2019 to 2031]:

  • Sterile Compounding Systems
  • Non-Sterile Compounding Systems

Hazardous Drug Compounding System Market by Application [Value from 2019 to 2031]:

  • Hospital Pharmacies
  • Outpatient/Community Pharmacies
  • Research and Development Laboratories
  • Others

Hazardous Drug Compounding System Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Hazardous Drug Compounding System Market

The global hazardous drug compounding system market has experienced rapid developments in the past few years, which are attributed to growing regulations and a safety focus in pharmaceutical compounding. Hazardous drug compounding is crucial in the preparation of drugs that are considered dangerous, such as chemotherapy agents. As awareness regarding the safe handling and preparation of these drugs increases, changes in regulations, technological advancements, and market demands are seen in countries such as the United States, China, Germany, India, and Japan. The market is responding with new innovations in compounding systems designed to protect healthcare workers and improve the overall efficiency of drug preparation.

  • United States: This market, especially in the United States, is growing at an incredible pace due to stringent regulations by the FDA and OSHA. The push by the FDA for stiffer standards on compounding hazardous drugs, as enshrined in the Drug Quality and Security Act, among others, will influence the market. Investments in safer and more efficient compounding technologies are being made by pharmaceutical companies to adhere to these regulations. In addition, the need for automated compounding systems is growing, with healthcare facilities looking for ways to reduce human error and exposure to hazardous drugs, thus providing a safer workplace for staff.
  • China: The Chinese hazardous drug compounding system market is rapidly growing, with the government strengthening its regulations on the safe handling of hazardous drugs. Growth in the Chinese pharmaceutical industry has also been stimulated through increasing demand for advanced drug compounding systems in oncology and chemotherapy treatments. Though the country has some difficulties with training workers and raising the public's awareness regarding safety standards, automation of compounding systems is the emerging trend. This change to automation will ensure that the drugs are prepared with greater efficiency and accuracy while at the same time reducing the dangers of handling hazardous drugs.
  • Germany: Germany is moving its hazardous drug compounding system market forward with emphasis on safety for the workers and adherence to the regulatory requirements. The European Union's efforts to increase the strictness of guidelines on the handling of drugs have led Germany to use more advanced compounding technologies to adhere to the new standards of safety. The country has been embracing the use of closed-system drug transfer devices (CSTDs) and automated compounding devices in reducing the risks of drug contamination and exposure. The German market is expected to grow further because of the need for safety in drug compounding, especially in hospitals and oncology clinics.
  • India: The hazardous drug compounding system market in India is increasing because of awareness about the risk associated with handling hazardous drugs. The pharmaceutical industry is expanding rapidly, and the number of cancer treatments is increasing. It is more crucial now than ever to have effective drug compounding systems. However, India lags behind in awareness and training in the right safety protocols. Still, there is a trend towards automation, which is reducing safety concerns and improving efficiency in drug compounding. According to the improvement and spreading awareness, India's hazardous drug compounding systems shall continue to market, which is gradually increasing.
  • Japan: Japan's hazardous drug compounding system evolves with a clear focus on safety with its precision. Such a country seeks advanced compounding systems due to the increasing interest in oncological treatments and striving healthcare worker protection standards. This means that the country's healthcare sector has increasingly begun to adopt automated systems and technology for safer and efficient compounding. Additionally, there is an increase in the proportion of elderly citizens in the population that further leads to more patients seeking chemotherapy treatment. Japan is likely to continue on a straight growth path in the hazardous drug compounding system market as it continues improving the safety standards surrounding the handling of hazardous drugs.

Features of the Global Hazardous Drug Compounding System Market

  • Market Size Estimates: Hazardous drug compounding system market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Hazardous drug compounding system market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Hazardous drug compounding system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hazardous drug compounding system market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hazardous drug compounding system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hazardous drug compounding system market by type (sterile compounding systems and non-sterile compounding systems), application (hospital pharmacies, outpatient/community pharmacies, research and development laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Hazardous Drug Compounding System Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Sterile Compounding Systems: Trends and Forecast (2019-2031)
  • 4.4 Non-Sterile Compounding Systems: Trends and Forecast (2019-2031)

5. Global Hazardous Drug Compounding System Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital Pharmacies: Trends and Forecast (2019-2031)
  • 5.4 Outpatient/Community Pharmacies: Trends and Forecast (2019-2031)
  • 5.5 Research and Development Laboratories: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Hazardous Drug Compounding System Market by Region

7. North American Hazardous Drug Compounding System Market

  • 7.1 Overview
  • 7.2 North American Hazardous Drug Compounding System Market by Type
  • 7.3 North American Hazardous Drug Compounding System Market by Application
  • 7.4 United States Hazardous Drug Compounding System Market
  • 7.5 Mexican Hazardous Drug Compounding System Market
  • 7.6 Canadian Hazardous Drug Compounding System Market

8. European Hazardous Drug Compounding System Market

  • 8.1 Overview
  • 8.2 European Hazardous Drug Compounding System Market by Type
  • 8.3 European Hazardous Drug Compounding System Market by Application
  • 8.4 German Hazardous Drug Compounding System Market
  • 8.5 French Hazardous Drug Compounding System Market
  • 8.6 Spanish Hazardous Drug Compounding System Market
  • 8.7 Italian Hazardous Drug Compounding System Market
  • 8.8 United Kingdom Hazardous Drug Compounding System Market

9. APAC Hazardous Drug Compounding System Market

  • 9.1 Overview
  • 9.2 APAC Hazardous Drug Compounding System Market by Type
  • 9.3 APAC Hazardous Drug Compounding System Market by Application
  • 9.4 Japanese Hazardous Drug Compounding System Market
  • 9.5 Indian Hazardous Drug Compounding System Market
  • 9.6 Chinese Hazardous Drug Compounding System Market
  • 9.7 South Korean Hazardous Drug Compounding System Market
  • 9.8 Indonesian Hazardous Drug Compounding System Market

10. ROW Hazardous Drug Compounding System Market

  • 10.1 Overview
  • 10.2 ROW Hazardous Drug Compounding System Market by Type
  • 10.3 ROW Hazardous Drug Compounding System Market by Application
  • 10.4 Middle Eastern Hazardous Drug Compounding System Market
  • 10.5 South American Hazardous Drug Compounding System Market
  • 10.6 African Hazardous Drug Compounding System Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Hazardous Drug Compounding System Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 BD Medical
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Equashield
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 ICU Medical
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Simplivia
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 B. Braun
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Baxter
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Comecer
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Grifols
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 ARxiUM
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Newlcon
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Hazardous Drug Compounding System Market
  • Figure 2.1: Usage of Hazardous Drug Compounding System Market
  • Figure 2.2: Classification of the Global Hazardous Drug Compounding System Market
  • Figure 2.3: Supply Chain of the Global Hazardous Drug Compounding System Market
  • Figure 2.4: Driver and Challenges of the Hazardous Drug Compounding System Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Hazardous Drug Compounding System Market ($B) by Type
  • Figure 4.3: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.1: Global Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Hazardous Drug Compounding System Market ($B) by Application
  • Figure 5.3: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 6.1: Trends of the Global Hazardous Drug Compounding System Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Hazardous Drug Compounding System Market (2019-2031)
  • Figure 7.2: North American Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Hazardous Drug Compounding System Market (2019-2031)
  • Figure 8.2: European Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 8.5: European Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Hazardous Drug Compounding System Market (2019-2031)
  • Figure 9.2: APAC Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Hazardous Drug Compounding System Market (2019-2031)
  • Figure 10.2: ROW Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Hazardous Drug Compounding System Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Hazardous Drug Compounding System Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Type
  • Figure 12.2: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Application
  • Figure 12.3: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Region
  • Figure 12.4: Emerging Trends in the Global Hazardous Drug Compounding System Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Hazardous Drug Compounding System Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Hazardous Drug Compounding System Market by Region
  • Table 1.3: Global Hazardous Drug Compounding System Market Parameters and Attributes
  • Table 3.1: Trends of the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 3.2: Forecast for the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Hazardous Drug Compounding System Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.4: Trends of Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.5: Forecast for Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.6: Trends of Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.7: Forecast for Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Hazardous Drug Compounding System Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.4: Trends of Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.5: Forecast for Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.6: Trends of Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.7: Forecast for Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.8: Trends of Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.9: Forecast for Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.1: Trends of the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.2: Forecast for the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Hazardous Drug Compounding System Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Hazardous Drug Compounding System Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.1: Trends of the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.2: Forecast for the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.1: Trends of the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.2: Forecast for the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.1: Trends of the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.2: Forecast for the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Hazardous Drug Compounding System Market (2019-2031)
  • Table 11.1: Product Mapping of Hazardous Drug Compounding System Suppliers Based on Segments
  • Table 11.2: Operational Integration of Hazardous Drug Compounding System Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Hazardous Drug Compounding System Revenue
  • Table 12.1: New Product Launches by Major Hazardous Drug Compounding System Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Hazardous Drug Compounding System Market